Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-03

FDA Approved: LETROZOLE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's original ANDA for letrozole (generic), enabling its marketing as a generic aromatase inhibitor. The approval covers the same indications as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (generic) (Letrozole)

Snippet

ORIG AP for LETROZOLE (LETROZOLE)